All data are based on the daily closing price as of July 18, 2025
p
Peptron
087010.KQ
211.64 USD
7.74
+3.80%
Overview
Last close
211.64 usd
Market cap
3.24B usd
52 week high
211.64 usd
52 week low
16.05 usd
Target price
25.15 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
1415.0152
Price/Book Value
44.3694
Enterprise Value
4.66B usd
EV/Revenue
1508.0959
EV/EBITDA
-17.5233
Key financials
Revenue TTM
4.18M usd
Gross Profit TTM
3.21M usd
EBITDA TTM
-7.72M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
111.86M usd
Net debt
N/A usd
About
Peptron, Inc. engages in the development of peptide-based medicines. The company's technologies include long acting; and SmartDepot, an ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of drug. Its research and development products include Luphere Depot for prostate cancer, endometriosis, uterine fibroids, premenopausal breast cancer, and puberty; SR-Octreotide for the treatment of acromegaly; SR-Exenatide to treat type 2 diabetes; and SR-Exenatide (PT320) for Parkinson's and Alzheimer's disease. Peptron, Inc. was founded in 1997 and is headquartered in Daejeon, South Korea.